NCT06013501

Brief Summary

This study aim to evaluate the effect of puppet show applied during subcutaneous injection to children aged 3-7 years with leukemia on the level of pain and fear experienced by children due to the intervention.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 3, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 30, 2023

Completed
5 months until next milestone

First Posted

Study publicly available on registry

August 28, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 3, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 3, 2024

Completed
Last Updated

February 5, 2024

Status Verified

February 1, 2024

Enrollment Period

1.9 years

First QC Date

March 30, 2023

Last Update Submit

February 2, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • procedure-related pain with Wong Baker Pain Rating Scale

    pain assessment with Wong Baker Pain Rating Scale by child

    change from Wong Baker Pain Rating Scale (5 minutes before the subcutaneous injection, 5 minutes after subcutaneous injection)

  • procedure-related fear with Child Fear Scale

    fear assessment with Child Fear Scale by child and parent

    change from Child Fear Scale (5 minutes before the subcutaneous injection, 5 minutes after subcutaneous injection)

  • procedure-related pain with The FLACC scale or Face, Legs, Activity, Cry, Consolability scale

    pain assessment with The FLACC scale or Face, Legs, Activity, Cry, Consolability scale by nurse

    change from The FLACC scale or Face, Legs, Activity, Cry, Consolability scale (5 minutes before the subcutaneous injection, 5 minutes after subcutaneous injection)

Secondary Outcomes (1)

  • Heart rate

    change from the heart rate at 10 minutes

Study Arms (2)

Puppet Show Group

EXPERIMENTAL

puppet show before and during subcutaneous injection

Behavioral: puppet show

Control group

NO INTERVENTION

standart care

Interventions

puppet showBEHAVIORAL

puppet show to the child before and during subcutaneous application

Puppet Show Group

Eligibility Criteria

Age3 Years - 7 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Child \<3 and \>7 years old
  • Medically unstable (dehydration, septic shock, sedation)
  • Children who are being treated for leukemia in the Pediatric Hematology Service will be included in the study.

You may not qualify if:

  • Not exposed to any other interventional procedure before (same day) subcutaneous intervention
  • Not expressing any pain before subcutaneous intervention
  • Heart rate to be within age-appropriate limits
  • Wong-Baker Pain Rating Scale score of 0 in the evaluation performed before the subcutaneous intervention (5 minutes ago)
  • Having a disability that cannot perceive the attempt and communicate (down syndrome, speech disorder, visual impairment)
  • The child and family do not know Turkish

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gülçin Özalp Gerçeker

Izmir, 35100, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Acute Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Gülçin Özalp Gerçeker, pHD

    Dokuz Eylul University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gülçin Özalp Gerçeker, pHD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: Randomised
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
pHD, Assoc. Prof.

Study Record Dates

First Submitted

March 30, 2023

First Posted

August 28, 2023

Study Start

January 3, 2023

Primary Completion

December 3, 2024

Study Completion

December 3, 2024

Last Updated

February 5, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations